There Should Be a Price to Pay for Knowingly Lying to Consumers
Why TINA.org wants the Supreme Court to address proof of harm in Lanham Act cases.
Carroll et al. v. Myriad Genetics, Inc.
22-cv-739, N.D. Cal.
(Feb. 2022)
Myriad’s Prequel Prenatal Screen
Falsely advertising that results are reliable and “highly accurate” when they are inaccurate approximately 85% of the time
Pending
Why TINA.org wants the Supreme Court to address proof of harm in Lanham Act cases.
Letters alert agencies and organizations to company’s improper marketing.
TINA.org discovers some roadblocks to unlocking this purportedly free offer.
New research points to “no.”
Why disclosures are key to protecting informed consumer choice and competition.